With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.
Image Credit: Shutterstock.com

Rethinking Kevin Warsh & 3 Jackson Hole Signals to Watch
12:15

Trump’s Approval Drop: Midterm Risks & Gridlock
12:24

Am I Entitled to Selangor’s Sukma Public Holiday
08:24